These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27108086)

  • 1. Multiplex SNaPshot-a new simple and efficient CYP2D6 and ADRB1 genotyping method.
    Ben S; Cooper-DeHoff RM; Flaten HK; Evero O; Ferrara TM; Spritz RA; Monte AA
    Hum Genomics; 2016 Apr; 10():11. PubMed ID: 27108086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic heart failure.
    Baudhuin LM; Miller WL; Train L; Bryant S; Hartman KA; Phelps M; Larock M; Jaffe AS
    Am J Cardiol; 2010 Aug; 106(3):402-8. PubMed ID: 20643254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study.
    Nieminen T; Uusitalo H; Mäenpää J; Turjanmaa V; Rane A; Lundgren S; Ropo A; Rontu R; Lehtimäki T; Kähönen M
    Eur J Clin Pharmacol; 2005 Dec; 61(11):811-9. PubMed ID: 16315032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of ADRB1 and CYP2D6 Polymorphisms With Antihypertensive Effects and Analysis of Their Contribution to Hypertension Risk.
    Chen L; Xiao T; Chen L; Xie S; Deng M; Wu D
    Am J Med Sci; 2018 Mar; 355(3):235-239. PubMed ID: 29549925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study.
    Fux R; Mörike K; Pröhmer AM; Delabar U; Schwab M; Schaeffeler E; Lorenz G; Gleiter CH; Eichelbaum M; Kivistö KT
    Clin Pharmacol Ther; 2005 Oct; 78(4):378-87. PubMed ID: 16198657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanopore sequencing of the pharmacogene
    Liau Y; Maggo S; Miller AL; Pearson JF; Kennedy MA; Cree SL
    Pharmacogenomics; 2019 Sep; 20(14):1033-1047. PubMed ID: 31559921
    [No Abstract]   [Full Text] [Related]  

  • 7. Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays.
    Scantamburlo G; Tziolia K; Zopf M; Bernardinelli E; Soyal SM; Civello DA; Vanoni S; Dossena S; Patsch W; Patrinos GP; Paulmichl M; Nofziger C
    Cell Physiol Biochem; 2017; 43(6):2297-2309. PubMed ID: 29073588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between ADRB1 and CYP2D6 gene polymorphisms and the response to β-blocker therapy in hypertension.
    Wu D; Li G; Deng M; Song W; Huang X; Guo X; Wu Z; Wu S; Xu J
    J Int Med Res; 2015 Jun; 43(3):424-34. PubMed ID: 25823457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy number variation and gene rearrangements in CYP2D6 genotyping using multiplex ligation-dependent probe amplification in Koreans.
    Kim J; Lee SY; Lee KA
    Pharmacogenomics; 2012 Jun; 13(8):963-73. PubMed ID: 22676200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
    Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
    Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
    Arneth B; Shams M; Hiemke C; Härtter S
    Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust CYP2D6 genotype assay including copy number variation using multiplex single-base extension for Asian populations.
    Kim EY; Lee SS; Jung HJ; Jung HE; Yeo CW; Shon JH; Shin JG
    Clin Chim Acta; 2010 Dec; 411(23-24):2043-8. PubMed ID: 20828547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolving discordant
    Hongkaew Y; Wang WY; Gaedigk R; Sukasem C; Gaedigk A
    Pharmacogenomics; 2021 Jun; 22(9):529-541. PubMed ID: 33998274
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationships.
    Chou WH; Yan FX; Robbins-Weilert DK; Ryder TB; Liu WW; Perbost C; Fairchild M; de Leon J; Koch WH; Wedlund PJ
    Clin Chem; 2003 Apr; 49(4):542-51. PubMed ID: 12651805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.
    Schaeffeler E; Schwab M; Eichelbaum M; Zanger UM
    Hum Mutat; 2003 Dec; 22(6):476-85. PubMed ID: 14635107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.
    Castaño-Amores C; Antúnez-Rodríguez A; Pozo-Agundo A; García-Rodríguez S; Martínez-González LJ; Dávila-Fajardo CL
    Biomed Pharmacother; 2023 Dec; 169():115869. PubMed ID: 37952358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication.
    Langaee T; Hamadeh I; Chapman AB; Gums JG; Johnson JA
    PLoS One; 2015; 10(1):e0113808. PubMed ID: 25625348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
    Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
    Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping.
    Heller T; Kirchheiner J; Armstrong VW; Luthe H; Tzvetkov M; Brockmöller J; Oellerich M
    Ther Drug Monit; 2006 Oct; 28(5):673-7. PubMed ID: 17038884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics.
    Kirchheiner J; Heesch C; Bauer S; Meisel C; Seringer A; Goldammer M; Tzvetkov M; Meineke I; Roots I; Brockmöller J
    Clin Pharmacol Ther; 2004 Oct; 76(4):302-12. PubMed ID: 15470329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.